These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10742697)

  • 1. Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
    Opasich C; Russo A; Mingrone R; Zambelli M; Tavazzi L
    Eur J Heart Fail; 2000 Mar; 2(1):7-11. PubMed ID: 10742697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
    Kieback AG; Iven H; Stolzenburg K; Baumann G
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):629-36. PubMed ID: 9781932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to treat acute decompensated heart failure in the 'beta-blocker era'?
    Marcondes-Braga FG; Mangini S; Ayub-Ferreira SM; Bocchi EA; Bacal F
    Eur J Heart Fail; 2010 Aug; 12(8):893-4. PubMed ID: 20675672
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure.
    Uretsky BF; Hua J
    Am Heart J; 1991 Jun; 121(6 Pt 1):1879-86. PubMed ID: 1674636
    [No Abstract]   [Full Text] [Related]  

  • 7. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
    Colucci WS
    J Am Coll Cardiol; 1988 Aug; 12(2):566-9. PubMed ID: 2899101
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.
    Thackray S; Easthaugh J; Freemantle N; Cleland JG
    Eur J Heart Fail; 2002 Aug; 4(4):515-29. PubMed ID: 12167393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M; Gronda E
    Ital Heart J Suppl; 2003 Jan; 4(1):3-7. PubMed ID: 12690928
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the combined haemodynamic effects of dobutamine and enoximone in patients taking beta adrenoceptor antagonists.
    Harvey WR; Monk CR
    Anaesth Intensive Care; 1995 Dec; 23(6):673-7. PubMed ID: 8669598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
    Metra M; Lombardi C; Carubelli V; Bettari L; Bugatti S; Danesi R; Lazzarini V; Monti A; Villa C; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):143S-148S. PubMed ID: 21416846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical care. Inotrope therapy.
    Place B
    Nurs Times; 1996 Aug 28-Sep 3; 92(35):55-7. PubMed ID: 8868896
    [No Abstract]   [Full Text] [Related]  

  • 15. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic therapy for the failing myocardium.
    Shipley JB; Hess ML
    Clin Cardiol; 1995 Nov; 18(11):615-9. PubMed ID: 8590529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inotropic agents for treatment of acute heart failure syndromes in intensive care].
    Rusca M; Liaudet L
    Rev Med Suisse; 2009 Dec; 5(229):2512-5. PubMed ID: 20084871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
    Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M
    J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The novelty in the treatment of heart failure].
    Reingardiene D
    Medicina (Kaunas); 2005; 41(7):625-31. PubMed ID: 16062032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous milrinone: therapeutic responses in heart failure.
    Braunwald E
    Am Heart J; 1991 Jun; 121(6 Pt 2):1937-8. PubMed ID: 2035423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.